Why is Kobo Biotech falling/rising?

As of 07-Jul, Kobo Biotech Ltd's stock is currently priced at Rs 2.40, reflecting a decrease of Rs 0.08, or 3.23%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 8.05%. It is trading below all significant moving averages and is close to its 52-week low, being only 3.33% away from Rs 2.32. The company has not declared any results in the last six months, indicating weak long-term fundamental strength, with net sales showing a dramatic annual decline of 100%. Additionally, the company has reported its lowest quarterly earnings, further contributing to the stock's negative sentiment.
In the broader market context, Kobo Biotech's performance over the past week shows a decline of 2.44%, while the Sensex has only decreased by 0.20%, highlighting a significant underperformance relative to the benchmark. Over the past year, Kobo Biotech has generated a return of -43.13%, contrasting sharply with the Sensex's positive return of 4.31%. This stark difference underscores the stock's poor performance in both the short and long term, as it has consistently lagged behind broader market trends and benchmarks, leading to a lack of investor confidence and participation.